These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23807696)

  • 1. Evaluating subject-level incremental values of new markers for risk classification rule.
    Cai T; Tian L; Lloyd-Jones D; Wei LJ
    Lifetime Data Anal; 2013 Oct; 19(4):547-67. PubMed ID: 23807696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study.
    Folsom AR; Chambless LE; Ballantyne CM; Coresh J; Heiss G; Wu KK; Boerwinkle E; Mosley TH; Sorlie P; Diao G; Sharrett AR
    Arch Intern Med; 2006 Jul; 166(13):1368-73. PubMed ID: 16832001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
    Arant CB; Wessel TR; Ridker PM; Olson MB; Reis SE; Delia Johnson B; Sharaf BL; Pauly DF; Handberg E; Zineh I; Sopko G; Kelsey SF; Noel Bairey Merz C; Pepine CJ
    Clin Cardiol; 2009 May; 32(5):244-50. PubMed ID: 19452486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts.
    Shah T; Casas JP; Cooper JA; Tzoulaki I; Sofat R; McCormack V; Smeeth L; Deanfield JE; Lowe GD; Rumley A; Fowkes FG; Humphries SE; Hingorani AD
    Int J Epidemiol; 2009 Feb; 38(1):217-31. PubMed ID: 18930961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting cardiovascular risk: so what do we do now?
    Lloyd-Jones DM; Tian L
    Arch Intern Med; 2006 Jul; 166(13):1342-4. PubMed ID: 16831997
    [No Abstract]   [Full Text] [Related]  

  • 7. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
    Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
    JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score.
    Albert MA; Glynn RJ; Ridker PM
    Circulation; 2003 Jul; 108(2):161-5. PubMed ID: 12835213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep duration, C-reactive protein and risk of incident coronary heart disease--results from the Framingham Offspring Study.
    Liu J; Yuen J; Kang S
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):600-5. PubMed ID: 24548663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do changes in traditional coronary heart disease risk factors over time explain the association between socio-economic status and coronary heart disease?
    Franks P; Winters PC; Tancredi DJ; Fiscella KA
    BMC Cardiovasc Disord; 2011 Jun; 11():28. PubMed ID: 21639906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.
    Cushman M; Arnold AM; Psaty BM; Manolio TA; Kuller LH; Burke GL; Polak JF; Tracy RP
    Circulation; 2005 Jul; 112(1):25-31. PubMed ID: 15983251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study.
    Wilson PW; Pencina M; Jacques P; Selhub J; D'Agostino R; O'Donnell CJ
    Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):92-7. PubMed ID: 20031795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
    Kones R
    Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension.
    Choi H; Cho DH; Shin HH; Park JB
    Circ J; 2004 Apr; 68(4):297-303. PubMed ID: 15056824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease--baseline findings of the PAIS project.
    Jousilahti P; Salomaa V; Rasi V; Vahtera E; Palosuo T
    Atherosclerosis; 2001 Jun; 156(2):451-6. PubMed ID: 11395043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity C reactive protein and risk of cardiovascular disease in China-CVD study.
    Dong Y; Wang X; Zhang L; Chen Z; Zheng C; Wang J; Kang Y; Shao L; Tian Y; Wang Z;
    J Epidemiol Community Health; 2019 Feb; 73(2):188-192. PubMed ID: 30530521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study.
    Penson PE; Long DL; Howard G; Toth PP; Muntner P; Howard VJ; Safford MM; Jones SR; Martin SS; Mazidi M; Catapano AL; Banach M
    Eur Heart J; 2018 Oct; 39(40):3641-3653. PubMed ID: 30165636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
    ; Kaptoge S; Di Angelantonio E; Lowe G; Pepys MB; Thompson SG; Collins R; Danesh J
    Lancet; 2010 Jan; 375(9709):132-40. PubMed ID: 20031199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.